2021
DOI: 10.1007/s11626-021-00544-y
|View full text |Cite
|
Sign up to set email alerts
|

MiR-23b-3p functions as a positive factor for osteoporosis progression by targeting CCND1 in MC3T3-E1 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 26 publications
0
7
0
Order By: Relevance
“…Besides, the expression levels of CCND1, MAPK8, MTOR in the treatment group showed different degrees of improvement. CCND1 has a relationship with various cancers by regulating cell proliferation and differentiation (38)(39)(40). CCND1 expression in the GIOP group significantly decreased and negatively regulated in the positive and TFDR group.…”
Section: Discussionmentioning
confidence: 98%
“…Besides, the expression levels of CCND1, MAPK8, MTOR in the treatment group showed different degrees of improvement. CCND1 has a relationship with various cancers by regulating cell proliferation and differentiation (38)(39)(40). CCND1 expression in the GIOP group significantly decreased and negatively regulated in the positive and TFDR group.…”
Section: Discussionmentioning
confidence: 98%
“…The overexpression of oar-miR-23b significantly inhibited the proliferation and migration of SDFs and promoted the apoptosis of SDFs. In the current literature, research on miR-23b and miR-133 has mainly focused on human diseases [ 51 , 52 , 53 ], while the impact of miR-23b and miR-133 on HF development and SDFs has not been reported. The coculture of DFs and keratinocytes modifies the activities of both cell types [ 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…A previous study reported that Ccnd1 was targeted by Let-7b to modulate osteoblast differentiation in mouse MC3T3-E1 cells [ 28 ]. MiR-23b-3p functions as a positive factor for the progression of osteoporosis via targeting Ccnd1 in MC3T3-E1 cells [ 29 ]. Ccnd1 expression was elevated by miR-539 up-regulation in osteoblasts [ 30 ].…”
Section: Discussionmentioning
confidence: 99%